SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001510964-21-000082
Filing Date
2021-11-30
Accepted
2021-11-30 17:13:18
Documents
14
Period of Report
2021-11-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20211130.htm   iXBRL 8-K 39196
2 EX-16.1 deloitteletter.htm EX-16.1 5252
3 EX-99.1 pressrelease11302021auditor.htm EX-99.1 7690
  Complete submission text file 0001510964-21-000082.txt   180623

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20211130.xsd EX-101.SCH 1933
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20211130_lab.xml EX-101.LAB 21488
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20211130_pre.xml EX-101.PRE 11112
7 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20211130_htm.xml XML 9105
Mailing Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121
Business Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 211460365
SIC: 2834 Pharmaceutical Preparations